Abeona Therapeutics Inc.
ABEO
$5.17
-$0.19-3.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -104.74% | 1,004.76% | -29.44% | 69.30% | -508.71% |
| Total Depreciation and Amortization | 15.63% | -5.77% | 5.03% | 7.48% | 5.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.08% | -3,724.69% | 10.46% | -124.05% | 175.32% |
| Change in Net Operating Assets | -208.77% | 557.42% | 10.79% | -2,055.06% | -107.27% |
| Cash from Operations | -12.79% | -2.08% | -11.13% | -35.35% | 3.55% |
| Capital Expenditure | 13.13% | -107.07% | -131.19% | -50.00% | 43.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -139.11% | 2,728.45% | -71.18% | 438.05% | 86.73% |
| Cash from Investing | -141.46% | 3,600.17% | -77.68% | 406.08% | 86.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -50.83% | 54.45% | 23.33% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 80.65% | 84.42% | 33.44% | -2,035.71% |
| Cash from Financing | -50.81% | 55.07% | 27.36% | 1,877.26% | -100.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.64% | 2,088.94% | -197.25% | 140.81% | -210.86% |